Bill of Health

APRIL 7, 2023

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. government. government substantially de-risking the vaccine development process.

COVID-19 Vaccine 147

COVID-19 Vaccine COVID-19 Governance Public Health 147

Healthcare IT Today

APRIL 28, 2023

But when it comes to putting the data in front of citizens, healthcare decision makers, government employees, and other key stakeholders, customer experience becomes a major part of the equation. Platform governance—an approach that establishes rules, practices, and standards—can create a hierarchy to manage cross organizational demands.

COVID-19 128

COVID-19 Governance Public Health FDA 128

Bill of Health

DECEMBER 6, 2024

Quantum-driven healthcare innovations present quantum-specific regulatory challenges, discussed in more detail below. The EU AI Act , proposed EU AI Liability Directive , and laws under the European Strategy for Data , such as the Data Governance Act , may also play roles. The regulatory landscape in the U.S.

FDA 100

FDA Governance Compliance Bioethics 100

Bill of Health

JULY 14, 2023

The federal government’s commitment to assuring that participants in human subject research provide fully informed consent dates back to the U.S But ethics review boards, often called IRBs are already required to pre-approve all materials used to advertise studies, as well as those presented directly to potential participants.

Informed Consent 130

Informed Consent FDA Public Health World Health 130

Bill of Health

OCTOBER 27, 2022

Newsom a legal principle that threatens to upend over a century of legal precedent recognizing the authority of state governments to ensure public health by mandating vaccines. Presently, among the fifty U.S. In 2021, the Supreme Court articulated in Tandon v. Throughout that period, federal courts have respected those decisions.

COVID-19 162

COVID-19 Public Health Governance COVID-19 Vaccine 162

Healthcare IT Today

JUNE 27, 2023

Food and Drug Administration (FDA) has recognized the problem and issued multiple guidance documents over the years—as recently as this March —to ensure the cybersecurity of medical devices. Although none of the FDA recommendations are legally enforceable, device manufacturers no longer have a choice but to comply.

Ransomware 119

Ransomware FDA Governance Hospitals 119

Bill of Health

FEBRUARY 27, 2024

There is a common and problematic misconception that colonization was an isolated historical event and that the present is somehow divorced from its precedent. To explore how colonization drives health inequities, we have to acknowledge the causal relationship between what is past and what is present and think critically about colonization.

Governance 124

Governance FDA World Health Health Outcomes 124

Health Law Advisor

MARCH 3, 2023

Food and Drug Administration (“FDA”) announced a much-anticipated draft guidance regarding the naming and labeling of plant-based milk alternatives. [1] The dairy industry has lobbied both federal and state governments to restrict the use of “milk” to only fluid “obtained by the complete milking of one or more healthy cows.” [2]

FDA 52

FDA Governance 52

Health Law Advisor

MARCH 1, 2023

To provide more value to readers, I’ve started submitting FOIA requests for unpublished data to produce additional insights into how FDA works. And what better first topic than data on FDA responses to FOIA requests. FDA has been releasing data on its FOIA process, specifically its FOIA logs , for a few years. We were wrong.

FDA 52

FDA Governance 52

HIT Consultant

MARCH 19, 2023

The unprecedented scale of the public health and marketing campaigns, the high prevalence of MCI in the population over 60 years old, and people’s fear of dementia will combine to create a tsunami of patients presenting to their healthcare providers seeking testing and treatment. billion marketing the medication.

US Department of Health and Human Services 98

US Department of Health and Human Services Hospitals COVID-19 FDA 98

Natalia Mazina

SEPTEMBER 20, 2021

The associations reminded the public that (1) ivermectin is not approved by the FDA for human use to prevent or treat Covid-19 and (2) Clinical trials and observational studies to evaluate the use of ivermectin to prevent and treat COVID-19 in humans have yielded insufficient evidence to recommend its use.

COVID-19 85

COVID-19 FDA Informed Consent Doctors 85

Healthcare Law Blog

MAY 31, 2022

These advancements, present challenges and raise novel questions as to how the current healthcare and life sciences legal regime would apply to the metaverse. In response to the growth of the metaverse and digital health generally, the FDA has been working to expand its guidance in the area. Data Privacy and Security. Healthcare Laws.

FDA 90

FDA HIPAA Medicare Medicare 90

Healthcare Law Today

DECEMBER 19, 2022

health care sector continues to grow at a rapid rate, and there is a recent government push for health care technologies, which have been identified as essential to U.S. market presents a tremendous opportunity for Israel-based health care companies, though the complexities and challenges of U.S. ” The U.S.

Telemedicine 64

Telemedicine FDA Licensing Governance 64

Healthcare IT Today

JULY 25, 2022

RPM devices work as medical devices which are governed by the FDA and related departments. Second, FDA cleared status should be well checked, not only the 510K, but also new issues with RPM devices, like whether cybersecurity principles and rules are fully performed, and all the security risks were tested by protocols, API and SDK.

FDA 98

FDA Licensing Governance Telemedicine 98

Bill of Health

JUNE 1, 2022

Over the past two years, the Supreme Court has shown unprecedented hostility to efforts by both state and federal government to stop the spread of what every day turns out to be an even more deadly pandemic. These decisions are devastating, and likely signal a continued attack on government authority , but they are not a reason to give up.

COVID-19 299

COVID-19 Governance FDA COVID-19 Vaccine 299

Bill of Health

OCTOBER 30, 2024

The lawsuits, arising from the desire to hold platforms accountable for exploiting children’s susceptibility to rewarding stimuli during development, present a novel theory of liability based solely on an algorithm’s ability to cause addiction rather than adverse mental health outcomes.

FDA 100

FDA Health Outcomes Public Health Governance 100

Hall Render

OCTOBER 18, 2022

Defendant pharmaceutical manufacturers applied for and received approval from the FDA to manufacture Gamunex at a facility converted for that purpose. FDA regulations require current Good Manufacturing Practices [cGMP] to be met or the drug shall be deemed adulterated and prohibited from sale. United States ex rel. at *1 & fn.

FDA 40

FDA Governance Fraud Compliance 40

Health Law Advisor

SEPTEMBER 6, 2022

A private equity client asked us recently to assess a rumor that FDA was on the warpath in enforcing the 510(k) requirement on medical devices from a particular region. Such a government initiative would significantly deter investments in the companies doing the importing. To be sure, FDA can have multiple reasons for refusing entry.

FDA 52

FDA Governance Hospitals 52

Physician Credentialing Company

OCTOBER 31, 2024

Medical history Physical examination Diagnostic procedures Therapeutic and preventive interventions Follow-up and outcomes Patient safety Category 3: Codes in this category are named temporary codes because they remain in this section till their FDA approval and evidence of their wide use by providers.

Medical Billing 52

Medical Billing Compliance Doctors Medicare 52

HIT Consultant

JANUARY 10, 2024

The government has called drug shortages a national security risk , and this is creating issues for today’s pharmacists on the front lines. When a hospital checks the FDA list, scrolls through hundreds of meds and learns of a drug shortage, the pharmacy staff scrambles to research what else is available on the market.

Hospitals 59

Hospitals FDA Nurses Governance 59

Health Care Law Brief

JUNE 2, 2022

Therefore, a telehealth platform operating in all 50 states will, for example, need to comport with the laws governing corporate formation, provider licensure, scope of practice, and telehealth encounters in all 50 states. Variety of Risks Present in Telehealth Arrangements. Does the platform treat certain data as consumer data?

Public Health 52

Public Health Compliance COVID-19 Licensing 52

Healthcare IT Today

JUNE 13, 2024

Kevin Paroda, Global Segment Manager, Acute Care at CenTrak The integration of AI in healthcare presents several challenges and ethical considerations, particularly regarding patient privacy, data security, and algorithmic bias. An AI hallucination is a false or misleading response that AI generates and presents as fact.

Governance 86

Governance HIPAA Hospitals Informed Consent 86

Healthcare Law Blog

MARCH 17, 2022

Section 1128A(a)(5) of the Act), the Proposed Arrangement nevertheless presented a minimal risk of fraud and abuse under the law on the facts presented. The Therapy is available only for clinical use under an FDA-approved, Category B Investigational Device Exemption (“IDE”) ( see 42 CFR 405.211(b)-(c) ).

US Department of Health and Human Services 52

US Department of Health and Human Services Informed Consent Medicare Medicare 52

AIHC

JUNE 14, 2023

The Federal Drug Administration & AI The Food & Drug Administration (FDA) released a discussion paper in 2019 and then an action plan on January 21, 2021 regarding Artificial Intelligence and Machine Learning, or AI/ML. One of the ways that OCR carries out this responsibility is to investigate complaints.

FDA 45

FDA HIPAA Compliance Regulatory Compliance 45

MedTrainer

JULY 13, 2023

Laws Are Behind the Technology Governing bodies are racing to keep up with the AI evolution, but very few have released policies to help guide compliance professionals. For example, when a human incorrectly codes an item, it happens one time. Berkeley Research Group’s Thomas F.

Compliance 52

Compliance Compliance Officers FDA Governance 52

HIT Consultant

MARCH 15, 2022

ClearDATA will also be presenting a HIMSS22 session entitled, “The Future of Connected Health: Operationalizing Privacy & Security,” at the AWS Partner Podium. These digital phenotyping solutions have been adopted by health organizations, tech, commercial and government entities.

Hospitals 98

Hospitals FDA Health Outcomes Doctors 98

Healthcare IT Today

MAY 5, 2023

The surge in genetic testing claims comes with a rise in fraud, waste and abuse across government and commercial payers. However, due to its nonspecific nature, this code can be abused by bad actors to request payment for services not covered, not performed or not FDA-approved. Common schemes include: Code stacking.

Fraud 72

Fraud Medicare Medicare Overpayments 72

Healthcare IT Today

JANUARY 3, 2024

This will present multiple challenges — increased difficulty in determining who to trust during incident response as well as determining when to deliver sensitive diagnosis and treatment plans when not face-to-face with patients. According to the ISC2 Cybersecurity Workforce Study, 2023, the U.S.

US Department of Health and Human Services 104

US Department of Health and Human Services Ransomware Hospitals HIPAA 104

HIPAA Journal

JUNE 27, 2022

Government entities are exempt. The ADPPA also has provisions for “sensitive covered data,” which is defined as “any information that describes or reveals the past, present, or future physical health, mental health, disability, diagnosis, or healthcare treatment of an individual.”

HIPAA 58

HIPAA FDA Health Insurance Governance 58

YouCompli

DECEMBER 3, 2024

From there, look at the regulations that govern your organization and see what applies so you include it. If you are in clinical research, this means looking at the FDA requirements, ICH-GCP Guidelines, and other applicable regulations.

Nurses 52

Nurses FDA Medicare Medicare 52

CMS.gov

OCTOBER 2, 2018

It’s no secret that the government often moves more slowly than private industry — some of our payment policies haven’t been updated in decades. This means that patients may experience unnecessary gaps between FDA approval of a technology and Medicare paying for the technology.

Medicare 44

Medicare Medicare Payment Systems FDA 44

HIPAA Journal

APRIL 5, 2023

Of those 300,000 complaints, more than 200,000 have been rejected because “the complaint did not present an eligible case for enforcement”. To the Federal Drug Administration to report adverse events and track FDA-regulated products. The complaint was withdrawn, or submitted after the 180-day limit.

HIPAA 74

HIPAA Hospitals Medical Personnel Compliance 74

Health Law Advisor

MARCH 7, 2023

Should the final rules limit the issuance of prescriptions of controlled medications to the FDA-approved indications contained in the FDA-approved labeling for those medications? DEA has specifically requested feedback on whether it should limit telemedicine prescribing to only the drug’s FDA-approved indications.

Telemedicine 52

Telemedicine COVID-19 FDA Compliance 52

Bill of Health

SEPTEMBER 29, 2022

In the July 29, 2022 notice, the USPTO set forth its views on the “duty of disclosure” and “duty of reasonable inquiry,” emphasizing the importance of consistency between statements made to the USPTO, the FDA, and other governmental agencies. Background Context.

FDA 130

FDA Governance Fraud Licensing 130

Health Law Advisor

AUGUST 10, 2023

But the question is, to what extent do health care providers need to worry about FDA requirements as they use AI? FDA has been regulating machine learning algorithms used in a clinical context for decades. It’s important to understand that FDA regulation isn’t punitive in the sense that it’s only intended to apply to bad people.

FDA 98

FDA Licensing Hospitals Medicaid 98

Bill of Health

APRIL 8, 2022

The Food and Drug Administration has authorized studies of psychedelics , including on a “breakthrough therapy” designation, but these drugs may not be handled by persons without a Drug Enforcement Administration license and outside an FDA approved setting. They may do well to follow suit with respect to psychedelics.

Licensing 298

Licensing FDA Governance 298

Bill of Health

MARCH 27, 2023

By declaring the pandemic over by fiat, the government is giving up the fight when they should be redoubling their efforts. The more bees present in a confined area, the greater the risk of being infected. In this framework, the CDC was treating cases of the virus like angry bees.

COVID-19 334

COVID-19 Public Health Governance COVID-19 Vaccine 334